| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Brain Research Institute, University of Zurich, 8029 Zurich, Switzerland [V. R. A., T. H., M. E. S.], and Department of Neurosurgery, University Hospital of Zurich, 8091 Zurich, Switzerland [N. O.]
Malignant gliomas infiltrate the brain preferentially along myelinated fiber tracts. Central nervous system (CNS) myelin, however, contains inhibitory proteins that block axon regeneration, neurite outgrowth, and cell spreading of astrocytes and fibroblasts. We tested 5 human brain tumor cell lines, 1 rat brain tumor cell line, and 29 short-term cultured specimens from human brain tumors for their ability to spread and migrate on a CNS myelin substrate. Low-grade and pilocytic astrocytoma, ependymoma, medulloblastoma, and meningioma cell lines as well as primary cultures were strongly sensitive to the inhibitory proteins present in the CNS myelin. In contrast, glioblastomas, anaplastic astrocytomas, and oligodendrogliomas were able to spread and migrate on CNS myelin-coated culture dishes, demonstrating that within the gliomas, the ability to overcome the inhibitory effects of the CNS myelin is correlated with the grade of malignancy of the original tumor. Cell spreading of glioblastomas and anaplastic astrocytomas specifically on a CNS myelin substrate was strongly inhibited by the metalloprotease blocker O-phenanthroline and the peptide derivative carbobenzoxy-Phe-Ala-Phe-Tyr-amide, whereas blockers for serine, aspartyl, and cysteine proteases had no effect. Enzymatic peptide degradation assays revealed the presence of a phosphoramidon-sensitive and thiorphan-insensitive metalloproteolytic activity in the plasma membranes of high-grade glioma cells. These results suggest a crucial involvement of a membrane-bound metalloendoprotease in the process of invasive migration of malignant gliomas along CNS white matter fiber tracts.
1 Supported by the Swiss National Science Foundation Grants 31-29981.90 and 31-45549.95, the Hartman-Müller Foundation (Zurich, Switzerland), and Regeneron Pharmaceuticals, Inc. (Tarrytown, NY). V. R. A. and T. H. contributed equally to this work.
2 Present address: Brain Research Laboratories, London Health Science Center, Victoria Campus, London, Ontario, N6A 4G5 Canada.
3 To whom requests for reprints should be addressed, at Brain Research Institute, University of Zurich, August-Forel-Strasse 1, 8029 Zurich, Switzerland.
Received 7/15/97. Accepted 10/24/97.
This article has been cited by other articles:
![]() |
N. de la Iglesia, G. Konopka, K.-L. Lim, C. L. Nutt, J. F. Bromberg, D. A. Frank, P. S. Mischel, D. N. Louis, and A. Bonni Deregulation of a STAT3-Interleukin 8 Signaling Pathway Promotes Human Glioblastoma Cell Proliferation and Invasiveness J. Neurosci., June 4, 2008; 28(23): 5870 - 5878. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Oertle, M. E. van der Haar, C. E. Bandtlow, A. Robeva, P. Burfeind, A. Buss, A. B. Huber, M. Simonen, L. Schnell, C. Brosamle, et al. Nogo-A Inhibits Neurite Outgrowth and Cell Spreading with Three Discrete Regions J. Neurosci., July 2, 2003; 23(13): 5393 - 5406. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Udayakumar, M. L. Chen, E. L. Bair, D. C. von Bredow, A. E. Cress, R. B. Nagle, and G. T. Bowden Membrane Type-1-Matrix Metalloproteinase Expressed by Prostate Carcinoma Cells Cleaves Human Laminin-5 {beta}3 Chain and Induces Cell Migration Cancer Res., May 1, 2003; 63(9): 2292 - 2299. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wild-Bode, M. Weller, A. Rimner, J. Dichgans, and W. Wick Sublethal Irradiation Promotes Migration and Invasiveness of Glioma Cells: Implications for Radiotherapy of Human Glioblastoma Cancer Res., March 1, 2001; 61(6): 2744 - 2750. [Abstract] [Full Text] |
||||
![]() |
A. T.J. Belien, P. A. Paganetti, and M. E. Schwab Membrane-type 1 Matrix Metalloprotease (MT1-MMP) Enables Invasive Migration of Glioma Cells in Central Nervous System White Matter J. Cell Biol., January 25, 1999; 144(2): 373 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Fields, M. E. Schwab, and J. Silver Does CNS Myelin Inhibit Axon Regeneration? Neuroscientist, January 1, 1999; 5(1): 12 - 18. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |